Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02061085
Brief Title: Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment (MERIBEL)

First Submitted : January 10, 2014
First Submitted that Met QC Criteria : February 11, 2014
First Posted : February 12, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 25, 2020
Last Update Posted : November 27, 2020